Tag: appeal

A very modest win: Generic Health gets 2% cut to Bayer’s $25 million damages

Posted onAuthorEsme Wong

Last year, Bayer was awarded more than $25 million (plus interest and indemnity costs) against Generic Health in the first Federal Court award of damages for pharmaceutical patent infringement.  In the appeal by Generic Health, the Full Court of the Federal Court allowed Generic Health a 2% discount to the $25 million damages originally awarded. What made the FCFCA give Generic Health such a modest discount? read more...
Subjects: Patents

United States Court of Appeals upholds PTAB decision on CRISPR Patent Interference

Posted onAuthorVeg Tran

The interference action between the University of California (UC) and Broad Institute (Broad) has seemingly come to an end, with the United States Court of Appeals for the Federal Circuit Court (CAFC) affirming that the patent claims that had been granted to Broad in relation to its CRISPR/Cas9 gene editing patents are separately patentable from the claims of a patent application made by UC. read more...
Subjects: Patents

Second throw of the dice unsuccessful: Full Federal Court confirms Hepatitis C drug patent is invalid

Posted onAuthorSuzy Madar

The recent decision of the Full Court in Idenix Pharmaceuticals v Gilead Sciences [2017] FCAFC 196 illustrates the power of the grounds of lack of utility and lack of sufficiency under section 40 of the Patents Act when challenging the validity of a patent. The decision concerned lack of utility and lack of sufficiency as those grounds read more...
Subjects: Patents

Full Court warns against dangerous affliction of parameteritis (and confirms invalidity of aripiprazole patent)

Posted onAuthorSuzy Madar

On Wednesday the Full Court of the Federal Court of Australia handed down a decision in which it upheld Justice Yates’ findings that Otsuka’s patent relating to aripiprazole, a drug used in the treatment of schizophrenia, is invalid for want of novelty and inventive step.  Otsuka had alleged that Generic Health’s aripiprazole products, which were registered read more...
Subjects: Patents